Published in Semin Ophthalmol on April 17, 2009
The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci (2010) 2.61
Screening and Treatment in Retinopathy of Prematurity. Dtsch Arztebl Int (2015) 1.26
Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy. Korean J Ophthalmol (2010) 0.93
Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood (2011) 0.92
A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease. Invest Ophthalmol Vis Sci (2013) 0.82
Capillary-free vascularized retina in patients with aggressive posterior retinopathy of prematurity and late retinal capillary formation. Korean J Ophthalmol (2013) 0.81
Laser treatment for retinopathy of prematurity. Lasers Med Sci (2011) 0.78
Ocular medicines in children: the regulatory situation related to clinical research. BMC Pediatr (2012) 0.78
Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity. Invest Ophthalmol Vis Sci (2014) 0.76
Stratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts. Gene (2014) 0.76
The omega-3 and retinopathy of prematurity relationship. Int J Ophthalmol (2017) 0.75
Efficacy of intravitreal captopril on oxygen-induced retinopathy in mice. Int J Ophthalmol (2011) 0.75
Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report. Br J Ophthalmol (1953) 10.53
Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci (1994) 10.46
Resolution of inflammation: the beginning programs the end. Nat Immunol (2005) 9.81
Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol (1954) 5.98
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics (2000) 5.36
Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA (2001) 5.33
Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed (2001) 4.38
Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med (2007) 4.36
Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res (1983) 4.07
Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med (2003) 3.80
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol (1994) 3.76
Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature (2004) 3.65
Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids (2001) 3.49
Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol (2006) 3.34
Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology (1991) 3.27
Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina (2008) 3.10
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res (2005) 3.03
Cost of preventing retrolental fibroplasia? Lancet (1973) 2.96
Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics (2003) 2.89
Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics (2003) 2.85
Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust (1951) 2.83
Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med (1999) 2.74
Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol (1952) 2.70
Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc (2004) 2.55
PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics (1977) 2.47
Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A (2001) 2.35
Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci (1996) 2.24
Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol (2006) 2.23
Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol (1956) 2.15
Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol (2007) 2.08
Further observations on cost of preventing retrolental fibroplasia. Lancet (1974) 2.02
Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med (1998) 1.97
Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology (2002) 1.94
Long term refractive outcome in eyes of preterm infants with and without retinopathy of prematurity: comparison of keratometric value, axial length, anterior chamber depth, and lens thickness. Br J Ophthalmol (2000) 1.94
Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration. Nat Med (2005) 1.91
Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study. Pediatrics (2002) 1.77
Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids (2006) 1.76
Recent increase in mortality from hyaline membrane disease. J Pediatr (1960) 1.76
Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol (2005) 1.68
Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol (1990) 1.63
Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol (2004) 1.35
Pathogenesis of retinopathy of prematurity. Semin Neonatol (2003) 1.32
Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study. Arch Ophthalmol (2008) 1.29
Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4). J Pharmacol Exp Ther (2002) 1.27
Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (1996) 1.15
Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies? Am J Clin Nutr (1997) 1.12
Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy. Curr Eye Res (1996) 1.11
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis (2006) 1.10
Retinopathy of prematurity: the life of a lifetime disease. Am J Ophthalmol (2006) 1.08
Adult retinopathy of prematurity: outcomes of rhegmatogenous retinal detachments and retinal tears. Ophthalmology (2001) 1.04
Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial. Pediatrics (1987) 1.03
A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics (2004) 1.02
Advanced cicatricial retinopathy of prematurity--outcome and complications. Br J Ophthalmol (1996) 0.96
Surgical management of late-onset retinal detachments associated with regressed retinopathy of prematurity. Ophthalmology (1990) 0.95
Vitamin E and retinopathy of prematurity. Follow-up at one year. Ophthalmology (1985) 0.95
Retrolental Fibroplasia in the Premature Infant: V. Further Studies on Fibroplastic Overgrowth of the Persistent Tunica Vasculosa Lentis. Trans Am Ophthalmol Soc (1944) 0.91
Frequency and natural history of retinopathy of prematurity (ROP). A prospective study in a Swedish city 1986-1990. Acta Ophthalmol Suppl (1993) 0.88
THE AETIOLOGY OF SPASTIC DIPLEGIA. A SYNTHESIS OF EPIDEMIOLOGICAL AND PATHOLOGICAL EVIDENCE. Dev Med Child Neurol (1964) 0.87
Surgical management of retinopathy of prematurity. Curr Opin Ophthalmol (2008) 0.83
A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature (2009) 3.44
Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc (2009) 3.31
Retinopathy of prematurity. Angiogenesis (2007) 3.20
Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics (2003) 2.85
The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci (2010) 2.61
Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest (2008) 2.45
Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol (2006) 2.23
Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2012) 2.19
Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood (2011) 2.02
One-year strabismus outcomes in the Infant Aphakia Treatment Study. Ophthalmology (2013) 2.00
Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci (2005) 1.88
IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci U S A (2007) 1.88
Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit. Pediatrics (2006) 1.85
Retinopathy of prematurity. Lancet (2013) 1.82
Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci (2008) 1.76
SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci (2010) 1.71
5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med (2011) 1.63
Molecular profiling of angiogenesis markers. Am J Pathol (2002) 1.57
Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest (2003) 1.50
Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol (2009) 1.39
Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci (2005) 1.32
Quantitative multi-gene transcriptional profiling using real-time PCR with a master template. Exp Mol Pathol (2005) 1.27
Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy. Circ Res (2010) 1.23
Secondary intraocular lens implantation after pediatric aphakia. J AAPOS (2011) 1.22
Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol (2010) 1.19
Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation (2011) 1.18
Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol (2010) 1.17
Mechanical stretch is a highly selective regulator of gene expression in human bladder smooth muscle cells. Physiol Genomics (2004) 1.17
High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis. Pediatrics (2010) 1.16
Blood gases and retinopathy of prematurity: the ELGAN Study. Neonatology (2010) 1.15
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis (2006) 1.10
Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci (2008) 1.06
Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion. Biochim Biophys Acta (2010) 1.03
Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo. Proc Natl Acad Sci U S A (2003) 1.03
Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol (2012) 1.02
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice. Invest Ophthalmol Vis Sci (2011) 0.99
Infantile cataracts. Int Ophthalmol Clin (2008) 0.96
A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants. Pediatr Res (2009) 0.95
Semaphorin 3F forms an anti-angiogenic barrier in outer retina. FEBS Lett (2013) 0.94
SOCS3 is an endogenous inhibitor of pathologic angiogenesis. Blood (2012) 0.92
Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice. PLoS One (2012) 0.90
Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema. Retina (2010) 0.89
Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report. Arterioscler Thromb Vasc Biol (2014) 0.88
Choroid sprouting assay: an ex vivo model of microvascular angiogenesis. PLoS One (2013) 0.87
A double-edged sword: erythropoietin eyed in retinopathy of prematurity. J AAPOS (2008) 0.85
Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration. J Clin Invest (2007) 0.85
Moderate GSK-3β inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy. Angiogenesis (2010) 0.84
Ghrelin modulates physiologic and pathologic retinal angiogenesis through GHSR-1a. Invest Ophthalmol Vis Sci (2011) 0.83
Neuronal sirtuin1 mediates retinal vascular regeneration in oxygen-induced ischemic retinopathy. Angiogenesis (2013) 0.83
Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety. Pediatr Res (2012) 0.83
Analysis of candidate genes for macular telangiectasia type 2. Mol Vis (2010) 0.82
Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come? Neonatology (2014) 0.82
Accuracy of intraocular lens power calculation formulae in children less than two years. Am J Ophthalmol (2012) 0.81
Lipid metabolites in the pathogenesis and treatment of neovascular eye disease. Br J Ophthalmol (2011) 0.81
Restraint of angiogenesis by zinc finger transcription factor CTCF-dependent chromatin insulation. Proc Natl Acad Sci U S A (2011) 0.79
Protective inflammasome activation in AMD. Nat Med (2012) 0.78
Corneal endothelial cell characteristics after pediatric cataract surgery. J Pediatr Ophthalmol Strabismus (2013) 0.78
An eye for discovery. J Clin Invest (2010) 0.77
Complications of pediatric cataract surgery. Semin Ophthalmol (2014) 0.77
Improving preterm ophthalmologic care in the era of accountable care organizations. Arch Ophthalmol (2012) 0.77
Author response: Different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains? Invest Ophthalmol Vis Sci (2012) 0.77
A radically twisted lipid regulates vascular death. Nat Med (2005) 0.76
RP-forme fruste. J Perinatol (2002) 0.75
Stem cells go for the eyes. Nat Med (2002) 0.75
Altered cholesterol homeostasis in aged macrophages linked to neovascular macular degeneration. Cell Metab (2013) 0.75
Congenital glaucoma. J Pediatr (2013) 0.75
Intra-arterial chemotherapy for group C retinoblastoma with adjacent high-flow infantile hemangioma. Ophthalmic Surg Lasers Imaging Retina (2013) 0.75
Surgical management of infantile cataracts in dystrophic epidermolysis bullosa. J AAPOS (2010) 0.75
Corrigendum: Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1. Nat Med (2016) 0.75